Mark Emberton was quoted in the Daily Telegraph today on the decision by the National Institute for Health and Clinical Excellence (NICE) to reverse its decision to offer High Intensity Focused Ultrasound (HIFU) for prostate cancer free on the NHS.
The full article is here.